Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 464 across all filing types
Latest filing 2020-08-06 Earnings Release
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a media release announcing the financial results for the first quarter ended June 30, 2020 (Q1FY21) of Lasa Supergenerics Limited. It contains summarized financial performance highlights such as revenues, EBITDA, PAT, and EPS comparisons with previous quarters and years. The document is titled as a 'Media Release' and is addressed to stock exchanges for record purposes. It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR), but rather a brief earnings announcement. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only. The document length is about 4884 characters, which is consistent with a media release rather than a full report. Hence, the appropriate classification is ER with high confidence. Q1 2021
2020-08-06 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a formal communication dated August 5, 2020, addressed to stock exchanges (BSE and NSE) reporting the outcome of a Board Meeting. The key points include approval of unaudited financial results for the quarter ended June 30, 2020, along with a Limited Review Report. The document also mentions the scheduling of the 5th Annual General Meeting and related notices. The presence of an Independent Auditor's Review Report on the quarterly unaudited standalone financial results pursuant to SEBI regulations and Indian Accounting Standard 34 (Interim Financial Reporting) confirms this is a quarterly financial report. The document contains substantive financial data and an auditor's review, which aligns with the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or certification but includes actual financial results and auditor review. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2021
2020-08-05 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2020. It is an intimation to stock exchanges and public about the meeting date and trading window closure. The document does not contain actual financial data or results but is an announcement of an upcoming board meeting and related procedural information. Therefore, it is not an Interim/Quarterly Report (IR) itself but a regulatory announcement about the board meeting. The appropriate classification is Regulatory Filings (RNS).
2020-07-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2020. It is addressed to stock exchanges and confirms dematerialization and securities handling compliance. The document is short (2981 characters) and primarily a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is a regulatory compliance filing related to securities and depository regulations, not an annual report, interim report, or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2020-07-16 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a compliance disclosure under Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It contains detailed related party transactions for the year ended 31 March 2020, including directors' remuneration, loans, processing charges, and outstanding balances. The document is a regulatory compliance filing disclosing related party transactions rather than a full financial report or audit report. It does not contain comprehensive financial statements or management discussion but is a mandated disclosure under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance disclosures that do not fit other specific report types.
2020-07-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window for insiders due to the upcoming financial results announcement for the quarter ended June 30, 2020. It references regulatory compliance related to insider trading but does not contain any financial data, report, or detailed analysis. The document length is only 1319 characters, indicating it is a brief announcement rather than a full report. It is not a financial report, earnings release, or management discussion. It is also not a certification or legal proceeding. The content fits best under a regulatory announcement category related to compliance and trading restrictions. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-07-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.